The Expression of LDL-R in CD8 + T Cells Serves as an Early Assessment Parameter for the Production of TCR-T Cells
In Vivo · 2023
DOI: 10.21873/invivo.13355 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2023. Verfasst von Y I Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, P.R. China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: The quantity and the phenotypes of desired T cell receptor engineered T (TCR-T) cells in the final cell product determine their in vivo anti-tumor efficacy. Optimization of key steps in the TCR-T cell production process, such as T cell activation, has been shown to improve cell quality. MATERIALS AND METHODS: Using a modified TCR (mTCR) derived from mice transducing PBMCs, we assessed the proportions of low-density lipoprotein receptor (LDL-R) and mTCR expressing cells under the various activation conditions of CD3/CD28-Dynabeads or OKT3 via flow cytometry. RESULTS: We demonstrate that the proportion of T cells expressing LDL-R post activation is positively correlated with the percentage of mTCR+CD8+ T cells with their less differentiated subtypes in the final product. In addition, we show that shifting the CD3/CD28-Dynabeads activation duration from a typical 48 h to 24 h can significantly increase the production of the desired mTCR+CD8+ T cells. Importantly, the percentages of TCR-T cells with less-differentiated phenotypes, namely mTCR central memory T cells (TCM), were found to be preserved with markedly higher efficiency when T cell activation was optimized. CONCLUSION: Our findings suggest that the proportion of LDL-R+ T cells may serve as an early assessment parameter for evaluating TCR-T cell quality, possibly facilitating the functional and economical improvement of current adoptive therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, P.R. China.
- Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, P.R. China.
- Department of Endocrine Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China.
- Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, P.R. China; tingtingli1191@cqmu.edu.cn.
- Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, P.R. China; aishunjin@cqmu.edu.cn.
Zitieren
APA
Wang, Y. I., Hao, Y. N., Shen, M. Y., Han, X. J., Wang, Y. M., Chen, S. Y., Wang, J. F., Wang, W., Li, T. T., & Jin, A. S. (2023). The Expression of LDL-R in CD8 + T Cells Serves as an Early Assessment Parameter for the Production of TCR-T Cells. In Vivo. https://doi.org/10.21873/invivo.13355
Vancouver
Wang YI, Hao YN, Shen MY, Han XJ, Wang YM, Chen SY, et al. The Expression of LDL-R in CD8 + T Cells Serves as an Early Assessment Parameter for the Production of TCR-T Cells. In Vivo. 2023. doi:10.21873/invivo.13355
BibTeX
@article{Wang2023,
author = {Wang, Y I and Hao, Ya-Nan and Shen, Mei-Ying and Han, Xiao-Jian and Wang, Ying-Ming and Chen, Si-Yin and Wang, Jun-Fan and Wang, Wang and Li, Ting-Ting and Jin, Ai-Shun},
title = {The Expression of LDL-R in CD8 + T Cells Serves as an Early Assessment Parameter for the Production of TCR-T Cells},
journal = {In Vivo},
year = {2023},
doi = {10.21873/invivo.13355}
}
EUVIMED